A new paradigm of cancer immunotherapy based on [18F]FDG and anti-PD-L1 mAb combination

被引：0
|
作者：
Wen, Xuejun [1 ]
Chen, Xiaoyuan [1 ]
Zhang, Xianzhong [1 ]
Guo, Zhide [1 ]
机构：
[1] Xiamen Univ, Xiamen, Peoples R China
来源：
NUCLEAR MEDICINE AND BIOLOGY | 2022年 / 108卷
基金：
中国国家自然科学基金;
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P-312
引用
收藏
页码：S219 / S220
页数：2
相关论文
共 50 条
  • [1] A Paradigm of Cancer Immunotherapy Based on 2-[18F]FDG and Anti-PD-L1 mAb Combination to Enhance the Antitumor Effect
    Wen, Xuejun
    Shi, Changrong
    Zeng, Xinying
    Zhao, Liang
    Yao, Lanlin
    Liu, Zhida
    Feng, Lixia
    Zhang, Deliang
    Huang, Jinxiong
    Li, Yesen
    Lin, Qin
    Chen, Haojun
    Zhuang, Rongqiang
    Chen, Xiaoyuan
    Zhang, Xianzhong
    Guo, Zhide
    CLINICAL CANCER RESEARCH, 2022, 28 (13) : 2923 - 2937
  • [2] Development of novel combination cancer immunotherapy using anti-PD-1 and anti-PD-L1 antibody
    Hasegawa, Hirotaka
    Sugiyama, Daisuke
    Kanda, Mitsuro
    Hayashi, Masamichi
    Tanaka, Chie
    Yamada, Suguru
    Nakayama, Goro
    Koike, Masahiko
    Nomoto, Shuji
    Fujiwara, Michitaka
    Kodera, Yasuhiro
    Nishikawa, Hiroyoshi
    CANCER SCIENCE, 2021, 112 : 741 - 741
  • [3] IMMUNOTHERAPY Benefit with anti-PD-L1
    Romero, Diana
    NATURE REVIEWS CLINICAL ONCOLOGY, 2017, 14 (02) : 70 - 70
  • [4] A Novel Anti-PD-L1 Vaccine for Cancer Immunotherapy and Immunoprevention
    Chen, Jie
    Liu, Hui
    Jehng, Tiffany
    Li, Yanqing
    Chen, Zhoushi
    Lee, Kuan-Der
    Shen, Hsieh-Tsung
    Jones, Lindsey
    Huang, Xue F.
    Chen, Si-Yi
    CANCERS, 2019, 11 (12)
  • [5] Discovery of small anti-PD-L1 peptides for cancer immunotherapy
    Liu, Hao
    Zhao, Zhen
    Li, Yuanke
    Cheng, Kun
    CANCER RESEARCH, 2019, 79 (13)
  • [6] ANTI-PD-1 AND ANTI-PD-L1 ANTIBODIES AS IMMUNOTHERAPY AGAINST CANCER: A STRUCTURAL PERSPECTIVE
    Cordova-Bahena, Luis
    Velasco-Velazquez, Marco A.
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2021, 73 (01): : 8 - 16
  • [7] MYASTHENIA GRAVIS CRISIS COMPLICATING ANTI-PD-L1 CANCER IMMUNOTHERAPY
    Chae, June
    Peikert, Tobias
    CRITICAL CARE MEDICINE, 2018, 46 (01) : 280 - 280
  • [8] Exploring Multivalency in the Development of Anti-PD-L1 Peptides for Cancer Immunotherapy
    Mamani, Umar-Farouk
    Ibrahim, Mohammed Nurudeen
    Liu, Yanli
    Fetse, John
    Lin, Chien-Yu
    Kandel, Sashi
    Nakhjiri, Maryam
    Koirala, Sushil
    Guo, Yuhan
    Alahmari, Mohammed
    Cheng, Kun
    PHARMACEUTICAL RESEARCH, 2024, : 2275 - 2288
  • [9] Discovery of Anti-PD-L1 Human Domain Antibodies for Cancer Immunotherapy
    Liu, Hao
    Liu, Yanli
    Zhao, Zhen
    Li, Yuanke
    Mustafa, Bahaa
    Chen, Zhijin
    Barve, Ashutosh
    Jain, Akshay
    Yao, Xiaolan
    Li, Guangfu
    Cheng, Kun
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [10] Retroperitoneal fibrosis in on-going anti-PD-1 immunotherapy detected with [18F]-FDG PET/CT
    Moreau, Aurelie
    Giraudet, Anne Laure
    Mognetti, Thomas
    Kryza, David
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (08) : 1758 - 1759
12345